HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plaintiff Puts ‘Clean Beauty’ To Test In Federal Court In Sephora USA Case

Executive Summary

The class action complaint in New York federal court suggests a parity between “clean” and natural claims in the understanding of beauty consumers.

You may also be interested in...



CTPA Takes Stand Against ‘Free From’ Claims, Urges Focus On Cosmetics’ ‘Positive Attributes’

In a position paper published on 6 October, the UK cosmetics trade group says “free from” claims can sow confusion among consumers, damage trust in brands and the industry, and lead to safe and effective ingredients no longer being used. In many instances, “free from” claims also may violate UK and EU law, according to CTPA.

PFAS Disclosure, Supplier Contracts Can Help Shield Against Litigation – Dentons US Attorneys

Cosmetics companies that disclose the presence of PFAS in their products and explain measures they are taking to minimize PFAS’ presence are better protected from lawsuits, says Dentons US attorney Michael Duvall.

CoverGirl Clean Fresh Is Starting Point For Brand’s Next Makeover, Coty CEO Nabi Suggests

Sue Nabi, who started as CEO at Coty in September, believes the company can do better than CoverGirl’s previous relaunch, which championed individual expression with the somewhat head-scratching tag, “I Am What I Makeup.” The brand’s future is in “clean,” she suggested during Coty’s first-quarter earnings call.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153227

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel